[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"current-user-roles":3,"user-subscription":3,"stock:celg":4,"stock-events:celg":11,"stock-overview:celg":16,"transactions-aggregate-celg":28},null,{"stockData":5,"volumeData":7,"stockDetails":3,"recommendations":9},["Reactive",6],[],["Reactive",8],[],["Reactive",10],[],{"ticker":12,"companyName":13,"sector":14,"earnings":3,"dividends":3,"splits":3,"politicianTrades":15},"CELG","Celgene Corporation","Healthcare",[],{"symbol":12,"name":13,"sector":14,"industry":17,"beta":18,"marketCap":19,"description":20,"website":21,"ipoDate":22,"country":23,"exchange":24,"currency":25,"image":26,"isEtf":27,"isActivelyTrading":27,"pe":3,"eps":3,"dividendYield":3},"Biotechnology",1.34,0,"Celgene Corporation is a global biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases.","https://www.bms.com","1987-06-18","US","NASDAQ","USD","https://images.financialmodelingprep.com/symbol/CELG.png",false,{"compliantItems":29,"nonCompliantItems":30,"politicians":31,"summary":49},[],[],[32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48],"Byron Donalds","Cleo Fields","David J. Taylor","Debbie Wasserman Schultz","Jared Moskowitz","Josh Gottheimer","Kevin Hern","Lisa C. McClain","Marjorie Taylor Greene","Nancy Pelosi","Pat Fallon","Seth Moulton","Shelley Moore Capito","Susie Lee","Terri A. Sewell","Tim Moore","Warren Davidson",{"total":19,"compliant":19,"nonCompliant":19,"complianceRate":50,"limited":19,"hasMore":27},100]